Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Nov;52(11):2732–2736. doi: 10.1172/JCI107468

Evidence that the Ciliary Inhibitor of Cystic Fibrosis is not an Antibody

Victoria Herzberg 1, Lynette Calvert 1, Barbara H Bowman 1
PMCID: PMC302540  PMID: 4201263

Abstract

An inhibitor of ciliary activity is present in the serum of cystic fibrosis (CF) patients and heterozygotes. Fractionation of CF serum has indicated that the inhibitor is associated with the serum IgG fraction. This study compared the activity of the CF inhibitor to that of rabbit antibody preparations directed against oyster cilia. The aim of this investigation was to determine whether the ciliary inhibitory mechanism in cystic fibrosis is related to a typical immunological reaction. Results from experiments utilizing fluorescent antibody techniques demonstrated that an antiserum directed against oyster ciliated epithelium binds immunologically with both human bronchial and oyster epithelial tissue. Results from experiments utilizing immunofluorescent tracing, passive hemagglutination, double immunodiffusion, and papain digestion, however, indicated that the interaction between the oyster cilia and the CF serum inhibitor was not a typical antigen-antibody reaction.

Full text

PDF
2732

Images in this article

2733Image
on p.2733
2734Image
on p.2734
2734Image
on p.2734

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEALE G. H., KACSER H. Studies on the antigens of Paramecium aurelia with the aid of fluorescent antibodies. J Gen Microbiol. 1957 Aug;17(1):68–74. doi: 10.1099/00221287-17-1-68. [DOI] [PubMed] [Google Scholar]
  2. Besley G. T., Patrick A. D., Norman A. P. Inhibition of the motility of gill cilia of Dreissensia by plasma of cystic fibrosis patients and their parents. J Med Genet. 1969 Sep;6(3):278–280. doi: 10.1136/jmg.6.3.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bowman B. H., Barnett D. R., Matalon R., Danes B. S., Bearn A. G. Cystic fibrosis: fractionation of fibroblast media demonstrating ciliary inhibition. Proc Natl Acad Sci U S A. 1973 Feb;70(2):548–551. doi: 10.1073/pnas.70.2.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bowman B. H., Lockhart L. H., McCombs M. L. Oyster ciliary inhibition by cystic fibrosis factor. Science. 1969 Apr 18;164(3877):325–326. doi: 10.1126/science.164.3877.325. [DOI] [PubMed] [Google Scholar]
  5. Bowman B. H., McCombs M. L., Lockhart L. H. Cystic fibrosis: characterization of the inhibitor to ciliary action in oyster gills. Science. 1970 Feb 6;167(3919):871–873. doi: 10.1126/science.167.3919.871. [DOI] [PubMed] [Google Scholar]
  6. Di Sant'Agnese P. A., Talamo R. C. Pathogenesis and physiopathology of cystic fibrosis of the pancreas. Fibrocystic disease of the pancreas (Mucoviscidosis). N Engl J Med. 1967 Dec 14;277(24):1287–contd. doi: 10.1056/NEJM196712142772404. [DOI] [PubMed] [Google Scholar]
  7. Kekwick R. A. The serum proteins in multiple myelomatosis. Biochem J. 1940 Sep;34(8-9):1248–1257. doi: 10.1042/bj0341248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kronvall G., Williams R. C., Jr Differences in anti-protein A activity among IgG subgroups. J Immunol. 1969 Oct;103(4):828–833. [PubMed] [Google Scholar]
  9. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  10. Mangos J. A., McSherry N. R. Sodium transport: inhibitory factor in sweat of patients with cystic fibrosis. Science. 1967 Oct 6;158(3797):135–136. doi: 10.1126/science.158.3797.135. [DOI] [PubMed] [Google Scholar]
  11. Mangos J. A., McSherry N. R. Studies on the mechanism of inhibition of sodium transport in cystic fibrosis of the pancreas. Pediatr Res. 1968 Sep;2(5):378–384. doi: 10.1203/00006450-196809000-00007. [DOI] [PubMed] [Google Scholar]
  12. Onkelinx E., Meuldermans W., Joniau M., Lontie R. Glutaraldehyde as a coupling reagent in passive haemagglutination. Immunology. 1969 Jan;16(1):35–43. [PMC free article] [PubMed] [Google Scholar]
  13. Press E. M., Piggot P. J., Porter R. R. The N- and c-terminal amino acid sequences of the heavy chain from a pathological human immunoglobulin IgG. Biochem J. 1966 May;99(2):356–366. doi: 10.1042/bj0990356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. SCHEIDEGGER J. J. Une micro-méthode de l'immuno-electrophorèse. Int Arch Allergy Appl Immunol. 1955;7(2):103–110. [PubMed] [Google Scholar]
  15. Schmoyer I. R., Fischer J. F., Brooks S. P. Fractionation of oyster cilia inhibitor from cystic fibrosis heterozygote serum. Biochem Biophys Res Commun. 1972 Mar 10;46(5):1923–1927. doi: 10.1016/0006-291x(72)90071-x. [DOI] [PubMed] [Google Scholar]
  16. Spock A., Heick H. M., Cress H., Logan W. S. Abnormal serum factor in patients with cystic fibrosis of the pancreas. Pediatr Res. 1967 May;1(3):173–177. doi: 10.1203/00006450-196705000-00003. [DOI] [PubMed] [Google Scholar]
  17. The T. H., Feltkamp T. E. Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method. Immunology. 1970 Jun;18(6):875–881. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES